Application no. and date | 02702623.6 (espacenet) (Federated) (European Patent Register), 20020305 | Patent/reg. no. and date | DK/EP 1458376, 20061004 | Publication date | 20040922 | Priority no. and date | GB 0129962, 20011214 | EP pub. no. and date |
EP 1458376 20040922 | Effective date | | Applicant/owner | Merus Labs Luxco II S.à r.l., 26-28 Rue Edward Steichen
2540 Luxembourg, LU | Applicant ref. no. | 128184 | Inventor | QUINN, Paul, Pfizer Global Res. and Development,
Ramsgate Road
Sandwich,
Kent CT13 9NJ, GB, SERDAREVIC, Dzelal, Pfizer Global Res. and Develop ment,
Ramsgate Road
Sandwich,
Kent CT13 9NJ, GB, SKILLERN, Laurence Howard, Pfizer Global Res. and Development,
Ramsgate Road
Sandwich,
Kent CT13 9NJ, GB, COLLI, Enrico, Piazza Pertini 9
20043 Arcore (MI), IT | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/4025 (2006.01) , A61P 13/10 (2006.01) | Title | Darifenacin til anvendelse i behandlingen af imperiøs vandladningstrang fremkaldt af overaktiv urinblære | Int. application no. | IB2002000664 | Int. publication no. | WO2003051354 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|